{"id":"https://openalex.org/W4289919967","doi":"https://doi.org/10.1158/1535-7163.21.3.1","title":"Phosphorylation of extracellular signal-regulated kinase 1 and 2, protein kinase B, and signal transducer and activator of transcription 3 are differently inhibited by an epidermal growth factor receptor inhibitor, EKB-569, in tumor cells and normal human keratinocytes","display_name":"Phosphorylation of extracellular signal-regulated kinase 1 and 2, protein kinase B, and signal transducer and activator of transcription 3 are differently inhibited by an epidermal growth factor receptor inhibitor, EKB-569, in tumor cells and normal human keratinocytes","alternate_titles":[],"publication_year":2004,"publication_date":"2004-01-01","ids":{"openalex":"https://openalex.org/W4289919967","doi":"https://doi.org/10.1158/1535-7163.21.3.1"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.21.3.1","doi":"https://doi.org/10.1158/1535-7163.21.3.1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.21.3.1","pdf_url":"https://aacrjournals.org/mct/article-pdf/3/1/21/1866753/21-27.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4289919967"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aacrjournals.org/mct/article-pdf/3/1/21/1866753/21-27.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065274145","display_name":"Maria Nunes","orcid":"https://orcid.org/0000-0002-5993-9667","observed_orcids":["https://orcid.org/0000-0002-5993-9667"]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maria Nunes","raw_affiliation_strings":["Oncology Research, Wyeth Pharmaceuticals, Pearl River, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Research, Wyeth Pharmaceuticals, Pearl River, NY","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110125695","display_name":"Celine Shi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Celine Shi","raw_affiliation_strings":["Oncology Research, Wyeth Pharmaceuticals, Pearl River, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Research, Wyeth Pharmaceuticals, Pearl River, NY","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044451793","display_name":"Lee M. Greenberger","orcid":"https://orcid.org/0000-0002-9583-6614","observed_orcids":["https://orcid.org/0000-0002-9583-6614"]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lee M. Greenberger","raw_affiliation_strings":["Oncology Research, Wyeth Pharmaceuticals, Pearl River, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Research, Wyeth Pharmaceuticals, Pearl River, NY","institution_ids":["https://openalex.org/I4403928396"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4403928396"],"apc_list":null,"apc_paid":null,"fwci":7.0514,"has_fulltext":true,"cited_by_count":148,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.97691248,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"3","issue":"1","first_page":"21","last_page":"27"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.015799999237060547,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epidermal-growth-factor-receptor","display_name":"epidermal growth factor receptor","score":0.7570000290870667},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.8080000281333923},{"id":"https://openalex.org/keywords/stat3-phosphorylation","display_name":"STAT3 phosphorylation","score":0.8949999809265137},{"id":"https://openalex.org/keywords/erk1-2-phosphorylation","display_name":"ERK1/2 phosphorylation","score":0.9319999814033508},{"id":"https://openalex.org/keywords/akt-phosphorylation","display_name":"Akt phosphorylation","score":0.9750000238418579},{"id":"https://openalex.org/keywords/keratinocytes","display_name":"keratinocytes","score":0.7760000228881836},{"id":"https://openalex.org/keywords/a431-cells","display_name":"A431 cells","score":0.859000027179718},{"id":"https://openalex.org/keywords/mda-mb-468-cells","display_name":"MDA-MB-468","score":0.925000011920929},{"id":"https://openalex.org/keywords/mcf-7-cells","display_name":"MCF-7 cells","score":0.9390000104904175},{"id":"https://openalex.org/keywords/phosphatidylinositol-3-kinase","display_name":"phosphatidylinositol 3-kinase","score":0.7099999785423279},{"id":"https://openalex.org/keywords/signal-transduction","display_name":"signal transduction","score":0.5580000281333923},{"id":"https://openalex.org/keywords/drug-induced-skin-toxicity","display_name":"drug-induced skin toxicity","score":0.4880000054836273},{"id":"https://openalex.org/keywords/cell-proliferation-inhibition","display_name":"cell proliferation inhibition","score":0.5260000228881836},{"id":"https://openalex.org/keywords/squamous-cell-carcinoma","display_name":"squamous cell carcinoma","score":0.5540000200271606}],"concepts":[{"id":"https://openalex.org/C2776362946","wikidata":"https://www.wikidata.org/wiki/Q424374","display_name":"Epidermal growth factor","level":3,"score":0.6512560844421387},{"id":"https://openalex.org/C47170353","wikidata":"https://www.wikidata.org/wiki/Q4649310","display_name":"A431 cells","level":5,"score":0.5937457084655762},{"id":"https://openalex.org/C171958077","wikidata":"https://www.wikidata.org/wiki/Q419333","display_name":"STAT protein","level":4,"score":0.5368618965148926},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.529558002948761},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.5239677429199219},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4982008934020996},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.49528685212135315},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.4829382300376892},{"id":"https://openalex.org/C2994460389","wikidata":"https://www.wikidata.org/wiki/Q681817","display_name":"Epidermoid carcinoma","level":3,"score":0.4806298613548279},{"id":"https://openalex.org/C2778923194","wikidata":"https://www.wikidata.org/wiki/Q14912019","display_name":"STAT3","level":3,"score":0.46161162853240967},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.45530954003334045},{"id":"https://openalex.org/C2777553839","wikidata":"https://www.wikidata.org/wiki/Q14330986","display_name":"Tyrosine phosphorylation","level":3,"score":0.4310632646083832},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.417140930891037},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3935199975967407},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.30941808223724365},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.17789578437805176},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14606976509094238},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.1266360580921173},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.07132738828659058},{"id":"https://openalex.org/C67082663","wikidata":"https://www.wikidata.org/wiki/Q3523816","display_name":"Molecular medicine","level":4,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.21.3.1","doi":"https://doi.org/10.1158/1535-7163.21.3.1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.21.3.1","pdf_url":"https://aacrjournals.org/mct/article-pdf/3/1/21/1866753/21-27.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.21.3.1","doi":"https://doi.org/10.1158/1535-7163.21.3.1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.21.3.1","pdf_url":"https://aacrjournals.org/mct/article-pdf/3/1/21/1866753/21-27.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4289919967.pdf","grobid_xml":"https://content.openalex.org/works/W4289919967.grobid-xml"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W170281222","https://openalex.org/W1482218984","https://openalex.org/W1525495286","https://openalex.org/W1546210634","https://openalex.org/W1931708823","https://openalex.org/W1963529390","https://openalex.org/W1965157624","https://openalex.org/W1971772761","https://openalex.org/W1972036696","https://openalex.org/W1976382352","https://openalex.org/W1990669035","https://openalex.org/W2010174111","https://openalex.org/W2018793834","https://openalex.org/W2019691808","https://openalex.org/W2024282024","https://openalex.org/W2026863172","https://openalex.org/W2030205108","https://openalex.org/W2030865745","https://openalex.org/W2044991100","https://openalex.org/W2049938167","https://openalex.org/W2058992264","https://openalex.org/W2064047613","https://openalex.org/W2074730236","https://openalex.org/W2098419457","https://openalex.org/W2099583536","https://openalex.org/W2099792017","https://openalex.org/W2113021215","https://openalex.org/W2114918609","https://openalex.org/W2135938911","https://openalex.org/W2139728179","https://openalex.org/W2146447599","https://openalex.org/W2148853136","https://openalex.org/W2159730182","https://openalex.org/W4211075026","https://openalex.org/W4255774136","https://openalex.org/W4299325671"],"related_works":["https://openalex.org/W2110311651","https://openalex.org/W2802403835","https://openalex.org/W2070986280","https://openalex.org/W2107109493","https://openalex.org/W2083505004","https://openalex.org/W135364155","https://openalex.org/W2113791134","https://openalex.org/W2235410201","https://openalex.org/W1979510101","https://openalex.org/W2062161492"],"abstract_inverted_index":{"EKB-569":[0,33,50,129,158,201,215,231],"is":[1,224,232],"an":[2],"irreversible":[3],"inhibitor":[4,133,163],"of":[5,17,22,49,76,114,134,164,184,190,200,236,247,258],"epidermal":[6],"growth":[7,21],"factor":[8],"receptor":[9],"(EGF-R)":[10],"tyrosine":[11],"kinase.":[12],"It":[13,223],"inhibits":[14],"EGF-induced":[15,165],"phosphorylation":[16],"EGF-R":[18,26,37,52,115,125,167,237,259],"and":[19,34,68,74,87,104,108,139,146,171,193,207],"the":[20,44,47,188,219,244],"tumors":[23],"that":[24,99,226],"overexpress":[25],"in":[27,83,93,136,169,180,204],"animal":[28],"models.":[29],"In":[30],"clinical":[31,256],"trials,":[32],"all":[35],"other":[36],"inhibitors":[38],"cause":[39],"skin":[40,227],"rashes.":[41],"To":[42],"understand":[43],"latter":[45],"phenomenon,":[46],"effect":[48],"on":[51],"as":[53,55],"well":[54],"downstream":[56],"signaling":[57],"to":[58,234,254],"phosphoinositide":[59],"3-kinase-protein":[60],"kinase":[61,66],"B":[62],"(AKT),":[63],"extracellular":[64],"signal-regulated":[65],"1":[67],"2":[69],"(ERK1/2),":[70],"or":[71],"signal":[72,240],"transducer":[73],"activator":[75],"transcription":[77],"3":[78],"(STAT3)":[79],"pathways":[80],"were":[81,116,212],"compared":[82],"tumor":[84],"cell":[85,97],"lines":[86,98],"normal":[88],"human":[89],"keratinocytes":[90],"(NHEK)":[91],"grown":[92],"tissue":[94],"culture.":[95],"Tumor":[96],"have":[100],"high":[101],"(A431":[102],"epidermoid":[103],"MDA-468":[105,140],"breast":[106,111],"carcinomas)":[107],"low":[109],"(MCF-7":[110],"carcinoma)":[112],"expression":[113],"used.":[117],"NHEK":[118,172,208],"cells":[119,141,153,173],"express":[120],"at":[121,197],"least":[122],"15-fold":[123],"less":[124],"than":[126],"A431":[127,170,206],"cells.":[128,209],"was":[130,159],"a":[131,161],"potent":[132,162],"proliferation":[135],"NHEK,":[137],"A431,":[138],"(IC50":[142,154,174],"=":[143,155,175],"61,":[144],"125,":[145],"260":[147],"nm,":[148],"respectively)":[149],"but":[150],"not":[151,217],"MCF-7":[152],"3600":[156],"nm).":[157,177],"also":[160],"phosphorylated":[166,191,194],"(pEGF-R)":[168],"20\u201380":[176],"The":[178,210],"reduction":[179],"pEGF-R":[181],"paralleled":[182],"inhibition":[183,189,235],"phosphotyrosine-705":[185],"STAT3,":[186,248],"while":[187],"AKT":[192],"ERK1/2":[195],"occurred":[196],"higher":[198],"concentrations":[199],"(75\u2013500":[202],"nm)":[203],"both":[205],"effects":[211],"specific":[213],"because":[214],"did":[216],"inhibit":[218],"nuclear":[220],"factor-\u03baB":[221],"pathway.":[222],"proposed":[225],"toxicity":[228],"associated":[229],"with":[230],"due":[233],"signaling.":[238],"Downstream":[239],"transduction":[241],"markers,":[242],"particularly":[243],"activation":[245],"status":[246],"may":[249],"be":[250],"useful":[251],"surrogate":[252],"markers":[253],"guide":[255],"development":[257],"inhibitors.":[260]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4289919967","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2022-08-06T00:00:00"}
